Since the business was founded, a key focus has been to establish strong patent protection around our key innovations.

This includes composition of matter modes of administration as well as the major elements of our manufacturing process.

Recce currently has three patent families including 15 patents or patent applications.

We are focused on constantly expanding, broadening and developing our intellectual property portfolio.

Recce is also committed to protecting our intellectual property estate of patent rights and trade secrets and the potential commercial and clinical advantages this protection provides for our proprietary technology. 

Our patent portfolio includes issued patent and patent applications in the world’s major markets, including the United States, Europe and Japan.

 

 

Wholly Owned Patents

Filed

Status

Expiry

Patent Family 1-Manufacture

Australia

Granted

2028

 

USA

Granted

2029

 

Europe

Granted

2028

 

Japan

Granted

2028

 

China

Granted

2028

Patent Family 2-Antibiotic Applications

 All PCT
Countries

 Pending

 2034

Patent Family 3-Viral Applications

 

Pending

 2034 

 

Sign up for news and updates

Receive news and information direct to your inbox.